Podcasts about rheumatologists

In this episode, we examine the evaluation of pain in patients with chronic inflammatory arthritis, with particular attention to spondyloarthritis and its clinical overlap with fibromyalgia. We explore why some patients continue to report persistent pain despite well-controlled inflammation, and the importance of distinguishing between active inflammatory disease and centralized pain syndromes such as fibromyalgia. Join us as we unpack the diagnostic nuances that can significantly impact patient care. 

In this episode, we explore a new approach to improving participation in lupus clinical trials by strengthening provider outreach and education. Our guest, Dr. Saira Sheikh of UNC Chapel Hill, discusses the TIMELY study, which focuses on involving healthcare providers and community health workers to better connect patients with trial opportunities. From roundtable discussions to changes in provider behavior, we highlight practical strategies that could improve how clinical trials are conducted. 

Not sure what Minimal Disease Activity or MDA is and how it relates to psoriatic arthritis and your joints? Listen as rheumatologist Dr. Arthur Mandelin explains what MDA means. Join hosts Jeff Brown and LB Herbert as they discuss minimal disease activity in psoriatic arthritis with nationally recognized rheumatologist Dr. Arthur Mandelin who identifies what it is, factors that influence achieving MDA, how long it takes to reach, and the impact on selection of treatments. Dr. Mandelin also addresses fatigue associated with inflammation, and what the future holds for minimal disease activity in psoriatic arthritis. Whether you have psoriasis or psoriatic arthritis, this episode offers information to help you understand management goals set by your doctor and the importance of attaining minimal disease activity. Timestamps: (00:00) Intro to Psound Bytes & guest welcome rheumatologist Dr. Arthur Mandelin (02:23) What is minimal disease activity (MDA) (04:32) MDA in comparison to ACR response criteria (07:36) Criteria for reaching MDA (09:20) Positive and negative factors of MDA (11:25) Importance of reaching MDA within a specific time frame (17:34) Length of time to reach MDA (18:48) Selection of treatment options and psoriatic arthritis domains (23:51) Inflammation and fatigue (26:59) A look at the future of minimal disease activity in psoriatic arthritis: Reaching ACR 90 (29:09) Advancements in psoriatic arthritis: Finding disease markers (33:40 ) If you have psoriasis, be aware of your risk for psoriatic arthritis 4 Key Takeaways: There are various ways to measure minimal disease activity in psoriatic arthritis to assess how the disease impacts quality of life.   Attaining and keeping minimal disease activity low through use of different therapy options offers a chance for better bone and joint outcomes. Advancements in psoriatic arthritis include attaining ACR90 and the potential for identifying key markers that make treatment selection more targeted and individualized. Those who have psoriasis need to realize bone and joint pain, and swelling in the joints may be related to their psoriatic skin disease and seek appropriate help.  Guest Bio: Dr. Arthur Mandelin is an Associate Professor of Medicine at Northwestern University Feinberg School of Medicine and the Department of Medicine Division of Rheumatology. Dr. Mandelin launched Northwestern University's first training program in musculoskeletal ultrasonography for rheumatology fellows. He is an active participant in the REASON Group which is a multi-center research collaboration devoted to using ultrasound guidance to obtain minimally invasive synovial tissue biopsies. Dr. Mandelin is a past member of the National Psoriasis Foundation's Medical Board where he served on consensus panels for the development of a variety of practice guidelines.  Resources Mentioned: National Psoriasis Foundation: https://www.psoriasis.org PEST Screener: https://www.psoriasis.org/psoriatic-arthritis-screening-test/ PsA Action Month 2025: https://www.psoriasis.org/psa-action-month/ NSAIDS  for Psoriatic Disease: https://www.psoriasis.org/advance/nsaids-for-psoriatic-disease-psa/ AMP (Accelerated Medicines Partnership): https://www.psoriasis.org/advance/progress-and-success- through-collaboration/  Tags: psoriasis, skin, psoriatic arthritis, minimal disease activity, ACR20, ACR50, ACR70, tender joints, bone erosion, joint swelling, enthesitis, inflammation, pain, fatigue, axial disease, spinal involvement, treatment, NSAIDS, biologics, personalized medicine, dermatology, National Psoriasis Foundation, AMP, Psound Bytes podcast, Soundbites podcast

Dr. Ronald Hoffman is joined by Dr. Aly Cohen, a board-certified rheumatologist and integrative medicine physician. They delve into the pervasive issue of environmental toxins and their adverse effects on health. Dr. Cohen, who also manages the environmental medicine curriculum at the University of California, Irvine, discusses insights from her new book "Detoxify: The Everyday Toxins Harming Your Immune System and How to Defend Against Them." The conversation covers practical steps to mitigate exposure to harmful chemicals, the rise of autoimmune diseases, and strategies for detoxification, including diet, exercise, and proper hydration. Dr. Cohen also shares her personal journey into environmental health, sparked by her dog's illness, and emphasizes the importance of proactive self-care in a world filled with toxins.

Dr. Hoffman continues his conversation with Dr. Aly Cohen, author of "Detoxify: The Everyday Toxins Harming Your Immune System and How to Defend Against Them."

This episode explores the evolving role of GLP-1 agonists in rheumatology, highlighting their potential to influence weight, inflammation, and overall disease activity. Our guest expert unpacks how adipose tissue contributes to systemic inflammation and why managing body weight is crucial in the treatment of rheumatic diseases. We delve into the underlying science, real-world clinical applications, and the exciting future of incorporating GLP-1 therapies into comprehensive rheumatologic care—offering fresh insight into a therapeutic class with game-changing potential. 

Lupus is a complex autoimmune disease that can affect many parts of the body — and often goes undiagnosed.

How to stay healthy and manage health conditions by reducing our tremendous environmental exposures to toxic chemicals!If you'd like to know more about how to reduce the harmful chemicals and toxins in our environment tune in to this week's guest Dr Aly Cohen, integrative rheumatologist and author of the new approachable, revolutionary book and 21-day program DETOXIFY: The Everyday Toxins Harming Your Immune System and How to Defend Against Them. Dr. Cohen demonstrates the surprising ways in which environmental toxins impact our bodies, linking specific symptoms and illnesses to everyday exposures. You'll uncover what's lurking in our water, food, personal care products, and household goods. More importantly, you'll discover simple and affordable steps to lead a more toxin-free life.Dr Aly empowers us no matter our lifestyle or budget, to make small, practical shifts that can substantially increase our quality of life and help to thwart future health risks.She shows us how to significantly reduce environmental exposure and enhance our detoxification process, by making easy and practical lifestyle changes that can alleviate chronic illness, strengthen our immune system, and ultimately extend our lifespan. You can find out more about Dr Aly Cohen's work on www.alycohenmd.com/And follow her on Linkedin @Aly Cohen MD and on Instagram @The Smart HumanYou can follow Host Lou Hamilton on Instagram @brave_newgirl and on Linkedin @LouHamiltoncreatelabPS. Lou helps you transform your health & wellbeing: LOU'S LIFE LAB SERVICES HEREFor Lou's creative transformation and art practice go to ART HIVE or LOUHAMILTONARTJoin our Brave New Girls retreats to reset and reconnect with what really matters to you. HEREMusic licensed from Melody Loops.Support the showBrave New Girls podcast is an Audio Archive Art Project with pioneering, creative & entrepreneurial women at the head of the curve, who are inspiring us on the airwaves, to work towards the health & wellbeing of ourselves and the planet. Brave New Girls podcast ranks in top 2.5% globally, and No 7 in the "45 Best UK Women's Podcasts to Listen to, in 2024", with Host Lou Hamilton, artist, author & wellbeing coach. Thank you for listening and please subscribe to keep up to date on new episodes as they're released.Lou is the founder of Brave New Girl Media- bringing you inspiration, support and growth. 1. INSPIRATION from courageous, creative women on Brave New Girls podcast working for the benefit of people and the planet. ️2. SUPPORT with 1:1 creative transformation coaching and our holistic, healthy, creative wellbeing retreats www.bravenewgirlmedia.com/wellbeing-retreat 3. GROWTH blogs to help you THRIVE.Sign up to our emails for inspiration, support & growth and LOU'S LIFE LAB free downloadable guide https://bravenewgirlmedia.comInsta @brave_newgirlBooks: Dare to Share- bestselling guide to podcast guesting FEAR LESS- coaching guide to living more bravely Brave New Girl- How to be Fearless Paintings & Public Art www.LouHamiltonArt.comInsta @LouHamiltonArt

Full Episode available: 5/3/2025 This Airing Pain episode explores how neurodivergent individuals experience pain, potential links to hypermobility, and the need for better education to support conditions like autism and ADHD.  Neurodiversity refers to the different ways a person's brain processes information.  It is an umbrella term used to describe a number of conditions including Autism or Autism Spectrum Conditions; ADHD; Dyscalculia; Dyslexia; Dyspraxia, or Developmental Coordination Disorder (DCD), and more. In this episode:  Dr. Clive Kelly discusses research on co-occurring conditions in neurodivergence, highlighting varied symptoms and how pain perception differs among individuals. Dr Jessica Eccles talks about her research into the relationship between joint hypermobility and neurodevelopmental conditions like ADHD and autism.  We hear from Ren Martin, an autistic learning disability nurse and mother of three neurodivergent children, and Ceri Reid of Parents Voices in Wales, advocating for better neurodiversity and mental health services. Throughout the episode, we hear from Imogen Warner, whose writings are featured in the Autistic Girls Network, and who highlights the reality of being a young autistic person. Contributors:  Dr. Clive Kelly, Consultant Physician and Rheumatologist, James Cook University Hospital and University of Newcastle-upon-Tyne.  Dr Jessica Eccles, Reader in Brain-Body Medicine at Brighton and Sussex Medical School.  Ren Martin, neurodevelopmental specialist.  Ceri Reid, neurodivergent mother and founder of Parents Voices in Wales. Imogen Warner, student with lived experience of autism and chronic pain.  Jane Green MBE, founder of SEDSConnective We are immensely grateful to The British Humane Association and The Heather Hoy Charitable Trust whose generous grants made this podcast possible.

In this episode, Dr. Kaur and Dr. Abhishek join us to discuss their recent study on acetaminophen, exploring how it compares to NSAIDs in safety and effectiveness. They break down their use of the Clinical Practice Research Datalink (CPRD), key findings—especially in arthritis patients—and what this means for clinical practice. It's an insightful look at how big data can challenge assumptions about one of the most used pain medications. 

Send us a textDr Chris McCarthy is a Clinical Fellow (Associate Professor) at Manchester School of Physiotherapy. He researches musculoskeletal interventions including exercise in long-term conditions and manual therapy. Prior to this he was a Consultant Physiotherapist at Imperial College Healthcare NHS Trust, St Mary's Hospital Paddington, London. After qualifying as a Physiotherapist in 1989 he undertook post-graduate training in Biomechanics and Manipulative therapy at Strathclyde and Coventry Universities before undertaking a PhD degree in rehabilitation within the faculty of Medicine at Manchester University. He was awarded a “Young Investigator of the Year” award in 2001, for his PhD studies, by the British Society of Rheumatologists.Chris has published over 60 peer reviewed papers on musculoskeletal rehabilitation and diagnosis and spoken at over 50 conferences. He has taught internationally on Manual Therapy, specifically on Combined Movement Theory, and lectures on five of the Masters courses in Manual Therapy in the UK. He is a member of the international advisory board for Manual Therapy journal and regularly reviews and publishes papers in the academic field of Manual Therapy. In this (at times clinical) conversation with Andrew Cox | Joint Dynamics he discusses his life's work, his PhD, some of the controversy surrounding hands on musculoskeletal therapy, and he shares his dream for best practice in the ever evolving field of health care and performance enhancementShow sponsor is Muvitality Medicinal Mushrooms for modern day health and wellness | Mu …Go to muvitality.com and use the code JD10 to receive a 10% discount on your purchase of Mu Functional mushrooms such as Lions Mane, Cordyceps, Chaga, Reishi, and Turkey tail functional mushroomsEnjoyHere are some useful links for this podcastLinked In - https://www.linkedin.com/in/combinedmovements/?originalSubdomain=ukCombined Movement Theory - https://images.app.goo.gl/awnrWEDA4repUc3W6Relevant episodesEpisode 120 - Your morning erections link to heart disease with Colin Symmonds https://podcasts.apple.com/us/podcast/episode-120-your-morning-erections-link-to-heart-disease/id1527374894?i=1000692986665Episode 107 - Father of Function Gary Gray https://podcasts.apple.com/us/podcast/episode-107-father-of-function-gary-gray-of/id1527374894?i=1000665866997JOINT DYNAMICS links:Joint Dynamics Facebook - https://www.facebook.com/JointDynamicsHongKong/Joint Dynamics Instagram -https://www.instagram.com/jointdynamics/Joint Dynamics Youtube - https://www.youtube.com/channel/UCRQZplKxZMSvtc6LxM5WckwJoint Dynamics Website - www.jointdynamics.com.hkHost - Andrew Cox -

In this episode, we dive into the evolving role of AI in rheumatology—exploring how it's already reshaping workflows, enhancing diagnostic accuracy, optimizing treatment selection, and helping us monitor patients remotely. We tackle big questions around bias, control over critical data and whether we're truly ready to let AI serve as our assistants—or even gatekeepers. From addressing workforce shortages to revolutionizing medical research and education, we examine both the promise and the pitfalls of this powerful technology, and why caution must guide its integration into our clinical decisions.

Today, I'm joined by Dr. Elizabeth Ortiz, a rheumatologist who takes a holistic approach to treating scleroderma—something that deeply resonates with me.Even after living with this disease for 25 years, I walked away from this conversation with new insights, and I know you will too. Tune in and discover valuable perspectives on managing scleroderma!

Dr. Jenna breaks down the key differences between pediatric and adult care, and shares practical tips to help you feel more confident and prepared—whether it's learning how to speak up during appointments, track your symptoms, or build a support system that really gets it.They also get real about mindset, movement, rest, and how to keep living a full, active life even with rheumatoid arthritis, juvenile idiopathic arthritis or a similar condition in the mix. If you're feeling unsure about what comes next, this conversation is full of encouragement, clarity, and little ways to start taking charge of your health journey.Episode at a glance:Why the Transition from Pediatric to Adult Rheumatology Care Matters: Understanding the key differences between pediatric and adult rheumatology care.Common Challenges: Navigating new doctors, treatment plans, and increased self-management responsibilities.Self-Advocacy Tips: How to confidently communicate with your new care team and take charge of your health.Building a Support System: The importance of finding a community, whether through friends, family, or patient groups.Finding the Right Rheumatologist: What to look for in a specialist who understands your needs and concerns.Words of Encouragement: Reassurance that you're not alone in this transition and that smoother adjustments are possible with the right resources.Medical disclaimer: All content found on Arthritis Life public channels was created for generalized informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment.Episode SponsorsRheum to THRIVE, an online course and support program Cheryl created to help people with rheumatic disease go from overwhelmed, confused and alone to confident, supported and connected. See all the details and join the program or waitlist now! 

On this episode, we chat with Dr. Sho Fukui about his recent study on rising uric acid levels and what's driving the increase. We dig into the links between weight, obesity, and gout, and hear how a huge health checkup database in Japan helped uncover some eye-opening trends. Dr. Fukui breaks down the findings in simple terms, shares how they compare to older studies like MRFIT, and talks about what they could mean for treatments like GLP-1s. Plus, we get a sneak peek at the exciting research he's working on next! 

In this episode, we dive into the complexities of IgG4-Related Disease (IgG4-RD), a mysterious and multi-organ condition that continues to challenge both patients and physicians. Back in January 2024, Dr. John Stone introduced us to the emerging landscape of treatments for IgG4-RD, and today, Dr. Matthew Baker joins us to provide an exciting update. With new therapies on the horizon, we explore the role of B and T cell pathogenesis, the limitations of traditional steroid treatments, and the off-label use of rituximab. We also take a closer look at the promising results from the “Mitigate Trial,” which offers hope for future strategies in managing this enigmatic disease. Join us as we discuss the evolving treatment landscape and what lies ahead for those affected by IgG4-RD. 

See all the Healthcasts at https://www.biobalancehealth.com/healthcast-blog If you are receiving testosterone or estradiol hormone pellet therapy, BioBalance Health wants to know if you have any of the following medical conditions that may require you to take antibiotics before any medical or dental procedure that breaks the skin, including pellet insertions and dental cleanings. BioBalance Health is dedicated to providing safe and effective hormone replacement with pellets for both men and women, and we want to ensure your health and safety throughout the process. We use sterile procedure guidelines, but certain conditions still require antibiotics to prevent local infections.   Conditions That May Require Pre-Procedure Antibiotics: If You Have Had a Joint Replacement.Some orthopedic surgeons recommend that patients take antibiotics before dental procedures to prevent infection in the joint that was replaced, while others may not. It is important that you follow the advice of YOUR orthopedic surgeon regarding antibiotics before any procedure. If your orthopedic surgeon has advised you to take antibiotics, please let us know. We can provide you with an antibiotic injection or a prescription to take the day of your pellet insertion that will prevent infection. If You Have Uncontrolled Type 1 or Type 2 Diabetes. If your blood sugar is not well-controlled, you may need antibiotics before your pellet insertion to prevent infection of the pellet insertion area. If you are treated and keep your sugars in good control you may not need antibiotics, however if your diabetes is in poor control, you are more likely to get an infection. It is important that you take antibiotics before your pellet insertion. The following blood sugar levels are considered indicators of poor diabetes control: HbA1c > 9.0 Fasting blood sugar > 150 mg/dL If your blood sugar exceeds these levels, or if your primary care doctor has recommended that you take antibiotics before dental cleanings or procedures, you should also take antibiotics before your pellet insertion to reduce the risk of infection.  If You Have an Autoimmune Disease and are on Immunosuppressive Treatment. If you are receiving treatment for an autoimmune condition that suppresses your immune system, you may be at higher risk for infection at the insertion site. In this case, you will need to take antibiotics before each pellet insertion. If your Rheumatologist does not believe antibiotics are necessary for you, you may proceed without them.  If You Are Receiving Cancer Treatment. Certain cancer treatments, especially those that suppress white blood cell production, can compromise your immune system. If you are undergoing such treatment, you should take antibiotics before or with your pellet insertion to prevent infection.   In Summary: If a doctor has advised you to take antibiotics for procedures, such as dental cleanings, you should also take antibiotics before your pellet insertion. Please inform us of any conditions or treatments that may require this precaution, and we will ensure you are properly prepared for your procedure.

I had an engaging and insightful conversation with rheumatologist, Dr. Michael York, a highly knowledgeable expert with a great sense of humor, on my latest podcast episode. We explored the key challenges affecting the hands, including Raynaud's, digital ulcers, and calcinosis, and their impact on patients. Dr. York also provided a fascinating explanation of why scleroderma research presents such unique difficulties.

Additionally, Cheryl & Dr Dada also explore how strength training—not to "bulk up," but to boost energy, focus, and joint stability—can be a game-changer for these diseases.Dr. Dada reassures newly diagnosed individuals to avoid the anxiety of worst-case scenarios online and instead focus on reliable information and gradual, sustainable lifestyle changes. She emphasizes that managing arthritis is a marathon, not a sprint, and that even 1% improvement each day adds up. With the right knowledge, support, and habits, you can take control of your health and live well with arthritis.Episode at a glance:Myths vs Facts for gout and osteoporosisStrength Training Benefits: Cheryl and Dr. Dada discuss how strength training improves joint stability, reduces fatigue, and enhances focus for arthritis, gout, and osteoporosis.Managing Anxiety: Cheryl and Dr. Dada discuss navigating the anxiety that comes with a new arthritis diagnosis, emphasizing the importance of reliable information.Patience & Progress: The value of taking a gradual approach—small daily improvements can lead to significant changes in quality of life.Empowering Patients: Dr. Dada emphasizes patient education and how it empowers individuals to make informed decisions about their care.Medical disclaimer: All content found on Arthritis Life public channels was created for generalized informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment.Episode SponsorsRheum to THRIVE, an online course and support program Cheryl created to help people with rheumatic disease go from overwhelmed, confused and alone to confident, supported and connected. See all the details and join the program or waitlist now! 

In this episode, we're joined by Dr. Atul Deodhar, a leading expert in the field of Axial Spondyloarthritis (AxSpA). Dr. Deodhar shares insights from his groundbreaking research on the pathophysiology, diagnosis, and management of AxSpA, particularly focusing on the efficacy and safety of IV secukinumab. We dive deep into his study, INVIGORATE-1, exploring the methods behind it, including the use of Interactive Response Technology, and the primary and secondary endpoints that shed light on this treatment's impact. We also discuss the latest data on patient preferences for subcutaneous versus intravenous immunomodulators and the implications of these findings. Tune in for an informative and engaging conversation that blends cutting-edge science with thoughtful reflections on patient care. 

Join Dr. Isabelle Amigues, rheumatologist, and Dr. Sarah Pederson, OBGYN specializing in infertility, as they dive into the connection between unexplained infertility and positive ANA. Discover how a collaborative approach can uncover hidden causes and optimize health for successful pregnancies. Don't miss this expert discussion packed with insights and actionable advice!More About Dr. Sarah Pederson at Vera Health & Fertility:She is a board-certified OBGYN who specializes in fertility, holistic medicine, and surgery. Originally from Phoenix, Arizona, she studied Biomedical Engineering (nerd alert!) at USC (University of Southern California) in Los Angeles, where she also attended medical school. After completing her OBGYN residency at UAB (University of Alabama at Birmingham), she moved to Denver, where she has been ever since.Her journey in women's health started when she was diagnosed with a large ovarian tumor and had to undergo major surgery. That surgery not only improved her fertility but also led her to have four beautiful kids. She is a Creighton Model Napro practitioner and has additional training in restorative reproductive surgery. When she's not working, she and her husband love traveling, camping, hiking, and skiing.You can find her here! https://verafertility.com/------------------------------------------------------------✨ Support my other channel, Rheumatology 101, for top Rheumatology tips, natural remedies, expert care, holistic healing, and the best treatment guidance for a healthier, pain-free life!https://www.youtube.com/@Rheumatology101/?sub_confirmation=1 

In this episode, we dive into a fascinating and often overlooked aspect of rheumatology: complications from diabetes that can mimic rheumatic diseases. Dr. Schiopu kicks off the discussion by shedding light on Diabetic Myonecrosis, a painful muscle condition that can be easily mistaken for other rheumatic disorders. We then explore Scleroderma, a skin-thickening muscle disorder that resembles systemic sclerosis (SSC) but has distinct underlying mechanisms. Dr. Schiopu shares invaluable insights on how to approach complex rheumatology consults in the hospital, emphasizing the importance of thoughtful diagnostic reasoning. She also discusses why sometimes the best approach in medicine is to avoid unnecessary tests and treatments, prioritizing patient care and accuracy in diagnosis. 

This week, we explore the genetics behind the production of antinuclear antibodies (ANA) in individuals without clinical autoimmune disease, using data from the All of Us registry. Our guest, Dr. Mehmet Hocaoglu shares insights into the significance of understanding ANA positivity and its potential genetic underpinnings, highlighting how large-scale genome-wide association studies (GWAS) can predict susceptibility to autoimmune conditions. We cover the study's methodology, the unique All of Us dataset, and the complexities of genetic analysis. Dr. Hocaoglu also discusses his personal journey in rheumatology research, offering advice for aspiring researchers, especially international medical graduates (IMGs).  

In this episode, we dive into the cutting-edge advancements presented by Dr. Christopher T. Ritchlin at Convergence 2024, where he shed light on the promising research set to transform the field of rheumatology. Join us as we break down key insights from one of the field's leading experts, exploring the future of precision medicine, the role of TRBV9 cells in axSpA, the impact of sex differences on PsA, and the potential of urinary biomarkers in Lupus Nephritis. Tune in for a fascinating discussion on what's next in rheumatology. 

 Airing Pain 148: Links between hypermobility and neurodivergence Released on: 5/3/2025 This Airing Pain episode explores how neurodivergent individuals experience pain, potential links to hypermobility, and the need for better education to support conditions like autism and ADHD.  Neurodiversity refers to the different ways a person's brain processes information.  It is an umbrella term used to describe a number of conditions including Autism or Autism Spectrum Conditions; ADHD; Dyscalculia; Dyslexia; Dyspraxia, or Developmental Coordination Disorder (DCD), and more. In this episode:  Dr. Clive Kelly discusses research on co-occurring conditions in neurodivergence, highlighting varied symptoms and how pain perception differs among individuals. Dr Jessica Eccles talks about her research into the relationship between joint hypermobility and neurodevelopmental conditions like ADHD and autism.  We hear from Ren Martin, an autistic learning disability nurse and mother of three neurodivergent children, and Ceri Reid of Parents Voices in Wales, advocating for better neurodiversity and mental health services. Throughout the episode, we hear from Imogen Warner, whose writings are featured in the Autistic Girls Network, and who highlights the reality of being a young autistic person. Contributors:  Dr. Clive Kelly, Consultant Physician and Rheumatologist, James Cook University Hospital and University of Newcastle-upon-Tyne.  Dr Jessica Eccles, Reader in Brain-Body Medicine at Brighton and Sussex Medical School.  Ren Martin, neurodevelopmental specialist.  Ceri Reid, neurodivergent mother and founder of Parents Voices in Wales. Imogen Warner, student with lived experience of autism and chronic pain.  Jane Green MBE, founder of SEDSConnective We are immensely grateful to The British Humane Association and The Heather Hoy Charitable Trust whose generous grants made this podcast possible. Time Stamps:  00:43 Understanding Neurodivergence and Pain 04:46 The Relationship between Hypermobility and Neurodivergence 12:06 Gender Differences in Diagnosis and Pain 13:49 Ren Martin's Personal Experience 32:27 Diagnosis for Neurodivergent Individuals 35:18 Challenges in Education for Neurodivergent Children 42:40 Training for Educators and Healthcare Workers Links Referred to in this Episode:     School toolkit for JHS and EDS - School Toolkit for EDS and JHS Parents Voices in Wales: Resources & Key Documents – Parents Voices in Wales CIC Autistic Girls Network: https://autisticgirlsnetwork.org/ Ehlers-Danloss Society: https://www.ehlers-danlos.com Hypermobility Syndrome Association. - The HMSA | The Hypermobility Syndromes Association Healios: https://healios.org.uk/ SEDSConnective: https://www.sedsconnective.org/  If you have any feedback about Airing Pain, you can leave us a review via our Airing Pain survey                                                                                                                                                                    

In this episode, our host is joined by Dr. Peter Nigrovic, an expert in Macrophage Activation Syndrome (MAS). Dr. Nigrovic, delves into the complexities of MAS. The discussion covers the syndrome's history, diagnostic challenges, mechanisms of inflammation, and the latest treatment strategies, including cytokine blockade, JAK inhibitors, and chemotherapy options. Dr. Nigrovic also reflects on his unique career journey, offering valuable insights into combining clinical practice and research, while sharing his philosophy for a fulfilling life in medicine and science. This episode is a thorough exploration of MAS and provides practical advice for clinicians dealing with this complex syndrome. Macrophage Activation Syndrome 

Send us a textAre you struggling with joint pain, feeling the effects of inflammation, or navigating the complex landscape of midlife health? This episode is your roadmap to understanding how lifestyle choices can transform your well-being.Join Dr. Orlena and renowned rheumatologist Dr. Neha Bhanusali as they unpack the mysteries of inflammation and joint health. You'll discover:• How your diet can be a powerful tool in fighting chronic inflammation• Surprising foods that can help protect your joints and reduce pain• Why movement is more important than ever as you age• The crucial connection between gut health and overall inflammationWhether you're experiencing joint stiffness, concerned about arthritis, or simply want to optimize your health, this conversation offers practical, evidence-based insights that can change how you approach wellness. Get ready to learn from an expert who believes in the power of lifestyle medicine and empowering your body's natural healing potential.Connect with Dr Neha Bhanusali :IG: https://www.instagram.com/plantforwardmd/Youtube: https://www.youtube.com/@PlantForwardMD  Want Dr Orlena's personal support? Book a free chat here: https://calendly.com/orlenakerek/breakthrough-call-pod

In part 2, we dig into the history of pulmonary hypertension. How did this strange diagnosis first get recognized, what does it have to do with cows with thick necks and urinary catheters in the heart? Intro 0:11 In this episode 0:17 Recap of part 1 0:26 How was pulmonary hypertension discovered? 2:38 1891 3:51 1901 5:07 1935 7:02 Hilar dance 12:58 Cardiac catheterization: 1929 15:03 When did cardiac catheterization become relevant? 20:10 1965: Aminorex 24:40 World Health Organization: 1975 26:37 1980s: toxic oil syndrome of Spain 28:20 Preview of part 3 33:15  Back to cardiac catheterization 34:08 Briskets disease 35:45 1947 37:56 Pulmonary physiology and prostaglandin therapies (in the next episode) 38:41 Schistosomiasis outbreaks in Egypt 1938 40:26 Chronic thromboembolism 45:03 Thanks for listening 48:16 We'd love to hear from you! Send your comments/questions to Dr. Brown at rheuminationspodcast@healio.com. Follow us on Twitter @HRheuminations @AdamJBrownMD @HealioRheum. References: Barst RJ. Ann Thorac Med. 2008;doi:10.4103/1817-1737.37832. Bodo R. J Physiol. 1928;doi:10.1113/jphysiol.1928.sp002447. Dresdale DT, et al. Am J Med. 1951;doi:10.1016/0002-9343(51)90020-4. Egypt. Stanford.edu. Published 2015. https://schisto.stanford.edu/pdf/Egypt.pdf. Hewes JL, et al. Pulm Circ. 2020;doi:10.1177/2045894019892801. Johnson S, et al. Am J Respir Crit Care Med. 2023;doi:10.1164/rccm.202302-0327SO. Newman JH. Am J Respir Crit Care Med. 2005;doi:10.1164/rccm.200505-684OE. Weir EK, et al. Circulation. 1996;doi:10.1161/01.cir.94.9.2216. Disclosures: Brown reports no relevant financial disclosures.

In this episode, we explore a potential paradigm shift in the treatment of Rheumatoid Arthritis. For years, pharmacologic interventions have been the cornerstone of management, but now a groundbreaking approach is emerging. John Tesser, principal investigator in a pioneering study, discusses the use of an implantable device that stimulates the vagus nerve. By tapping into the body's nervous system to reduce inflammation, this novel approach offers a promising alternative to traditional drug treatments. Tune in to learn how this innovative technology could reshape the future of Rheumatoid Arthritis care. 

Together, Cheryl and Dr. Ortiz debunk common myths about RA and tackle important topics like medication hesitancy, lifestyle interventions, and the balance between the two. Dr. Ortiz reassures listeners that while factors like nutrition, sleep, exercise, and stress management can help, “just because lifestyle can help doesn't mean lifestyle caused it.”They also discuss how to make the most of your doctor's appointments—because being prepared can help you feel more confident and in control. Plus, they dive into the emotional side of living with a chronic illness and the uncertainty that comes with it. Dr. Ortiz shares strategies doctors can use to provide reassurance, even when the path forward isn't always clear.Finally, they explore concierge medicine and why Dr. Ortiz transitioned to this model of care. And as a reminder to anyone feeling overwhelmed, Cheryl and Dr. Ortiz leave listeners with this thought: “Everyone's got something.” RA may be part of your story, but it doesn't define you—you can still build a life that feels full and thriving. Episode at a glance:Why Dr Ortiz Became a Rheumatologist: The importance of building a long term relationship with your patients and searching for answers in the gray areas of medicine.Tips for patients and doctors to communicate and connect better: Dr Ortiz shares practical tips for improving your connection with your doctor.Medication Hesitancy and Lifestyle: Dr. Ortiz and Cheryl reflect on the importance of understanding medication efficacy, and how some evidence-based lifestyle interventions can be an important adjunct in your care.Busting myths about rheumatoid arthritis: Dr. Ortiz and Cheryl address common misconceptions Dr. Ortiz has found in her Connected Rheumatology YouTube channel and Cheryl has found on her Arthritis Life social channelsEmpowering Mindset for a New Diagnosis: Your diagnosis is not your fault, but you do have control over how you respond.Shifting perspective: “Everyone's got something” – you're not alone in this journey.Living a Full Life with RA: Thriving means building a life beyond your condition.Medical disclaimer: All content found on Arthritis Life public channels was created for generalized informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment.Episode SponsorsRheum to THRIVE, an online course and support program Cheryl created to help people with rheumatic disease go from overwhelmed, confused and alone to confident, supported and connected. See all the details and join the program or waitlist now! 

Dr. Arthur Yee of Hospital for Special Surgery in New York City, believes rheumatologists are uniquely qualified to treat Sarcoidosis -- yet many of them shy away from sarc patients.  In this episode of the FSR Sarc Fighter Podcast, Dr. Yee explains why sarc patients can be scary to doctors.  He also looks at the history of Sarcoidosis and the treatment patterns that have evolved over time.  He also explains what beryllium miners have in common with people who have had tattoos -- and how all of that relates to sarcoidosis.    Show Notes: More on Dr. Arthur Yee: https://www.hss.edu/physicians_yee-arthur.asp What is a TNF inhibitor: https://www.webmd.com/rheumatoid-arthritis/tnf-inhibitor-inflammation Why Rheumatologists need to be more active in treating Sarcoidosis Patients: https://www.the-rheumatologist.org/article/the-rheumatologists-role-in-sarcoidosis/?singlepage=1   MORE FROM JOHN: Cycling with Sarcoidosis http://carlinthecyclist.com/category/cycling-with-sarcoidosis/ Biking 4 Boomers on Tic Tok. https://www.tiktok.com/@biking.4.boomers Do you like the official song for the Sarc Fighter podcast?  It's also an FSR fundraiser! If you would like to donate in honor of Mark Steier and the song, Zombie, Here is a link to his KISS account.  (Kick In to Stop Sarcoidosis)  100-percent of the money goes to the Foundation.  https://stopsarcoidosis.rallybound.org/MarkSteier The Foundation for Sarcoidosis Research https://www.stopsarcoidosis.org/ Donate to my KISS (Kick In to Stop Sarcoidosis) fund for FSR  https://stopsarcoidosis.rallybound.org/JohnCarlinVsSarcoidosis?fbclid=IwAR1g2ap1i1NCp6bQOYEFwOELdNEeclFmmLLcQQOQX_Awub1oe9bcEjK9P1E My story on Television https://www.stopsarcoidosis.org/news-anchor-sarcoidosis/ email me  carlinagency@gmail.com #sarcoidosis #sarcoidosisawareness #          

In this series, we dive into what rheumatologists should know about pulmonary hypertension, starting an interview with Joseph Parambil, MD, where we learn about the disease, when to suspect and how to work up! Intro 0:11 In this episode 0:16 Preview of the four-part series 4:46 Interview with Joseph Parambil, MD 6:27 How did you become interested in pulmonary hypertension? 7:02 Brown and Parambil discuss the histology of pulmonary hypertension. 10:13 Brown and Parambil discuss a case of pulmonary hypertension. 12:26 What is pulmonary hypertension and what does that mean for a rheumatologist? Where is pulmonary hypertension happening? 13:25 Describe the different groups of pulmonary hypertension. 19:51 A note about Dr. Chatterjee 20:25 Brown and Parambil discuss the groups of pulmonary hypertension. 23:35 What should we know about evaluating patients with pulmonary hypertensions? 26:51 Brown and Parambil discuss bendopnea and other signs of pulmonary hypertension. 29:58 What about the heart sound? 33:06 What should we look for in patients who we suspect to have pulmonary hypertension? 36:52 What should we look for in the tricuspid jet? 38:18 Brown and Parambil discuss the use of echocardiograms in pulmonary hypertension. 39:28 Tell us about the threshold of diagnosis. 40:47 What is the difference between the mean pressure and the wedge pressure? 41:41 What about the role of the pulmonary function test? 43:55 Summary 46:41 Do you think the pulmonary hypertension in scleroderma and lupus are different entities? 48:37 Brown and Parambil discuss the connection of autoimmune disease and pulmonary hypertension. 50:49 Coming up in episode 91 51:50 Thanks for listening 52:25 Disclosures: Brown and Parambil report no relevant financial disclosures. Joseph Parambil, MD, is a staff member in the Respiratory Institute and the director of the HHT Center of Excellence and the Vascular Anomalies Center at the Cleveland Clinic. He is associate professor of medicine at Cleveland Clinic's Lerner College of Medicine. He is certified by the American Board of Internal Medicine with additional specialty certification in pulmonary medicine and critical care medicine. We'd love to hear from you! Send your comments/questions to Dr. Brown at rheuminationspodcast@healio.com. Follow us on Twitter @HRheuminations @AdamJBrownMD @HealioRheum.

In this episode, we explore the unique challenges and considerations in treating older adults, focusing on the need for a different approach to care due to polypharmacy and multimorbidity. We delve into the complexities of managing these patients, emphasizing the importance of understanding frailty—how to assess, prevent, and address it. The discussion also covers late-onset rheumatoid arthritis, its distinction from rheumatoid arthritis, and why it often goes underdiagnosed and undertreated. We introduce the 5 M's framework; a geriatric care model that helps clinicians focus on what truly matters to older adults. Additionally, we address the role of palliative care in rheumatology, highlighting its importance beyond end-of-life care, and provide guidance on shared decision-making with older adults and their families to ensure patient-centered outcomes.   

If you're a healthcare provider or a storytelling enthusiast, you'll enjoy this episode featuring Dr. Jason Liebowitz. A practicing rheumatologist and accomplished writer, Dr. Liebowitz discusses his journey toward becoming a physician-writer, how writing helps him process his experiences, and the art of storytelling in medicine, especially for a wider audience in today's complex healthcare landscape. 

Today, we have an incredible guest joining us—rheumatologist Dr. David Collier. With 28 years as a Professor of Medicine at the University of Colorado Medical School and 25 years leading the scleroderma clinic, Dr. Collier is a true expert in the field. Currently, he's consulting with Kyverna Therapeutics, working on groundbreaking (CAR) T-cell therapy.We've all been hearing the buzz about this innovative treatment for scleroderma, and today, we're diving in to learn what it's all about. Get ready for a fascinating science lesson—you won't want to miss this! Let's get started!

On this episode, hear the 2024 updates on COVID-19, long COVID and the latest developments in research in rheumatology. Hosted by Dr. Leonard Calabrese. Intro 0:12 In this episode 0:21 Coming up on Healio Rheuminations 0:56 COVID-19, long COVID and the rheumatologist with Leonard Calabrese, DO 2:19 Questions 3:12 Long COVID 4:46 Calabrese's bias 10:15 The evidence 13:08 Auto antibodies 14:54 Why does the body develop auto antibodies? 17:47 COVID-19 and epidemiologic association 22:25 New clinical entity 26:40 Therapeutic implications 31:00 In conclusion 32:00 Thanks for listening 33:18 Leonard H. Calabrese, DO, is the chief medical editor, Healio Rheumatology, and professor of medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, and RJ Fasenmyer chair of clinical immunology at the Cleveland Clinic. Disclosures: Calabrese reports professional relationships with AbbVie, AstraZeneca, Bristol Myers Squibb, Galvani, Genentech, GlaxoSmithKline, Janssen, Novartis, Regeneron, Sanofi and UCB. We'd love to hear from you! Send your comments/questions to Dr. Brown at rheuminationspodcast@healio.com. Follow us on Twitter @HRheuminations @AdamJBrownMD @HealioRheum.

In this episode we explore the role of Neutrophil Extracellular Traps (NETs) in systemic lupus erythematosus (SLE). Dr. Mariana Kaplan, Chief of the Systemic Autoimmunity Branch at the National Institute of Arthritis Musculoskeletal and Skin Diseases, joins the discussion to break down the complex immunological mechanisms driving lupus, focusing on the contribution of NETs and Low-Density Granulocytes (LDGs) to disease activity and tissue damage. The conversation delves into the potential for these biological markers to improve diagnosis and treatment strategies, particularly in the context of lupus flares and cardiovascular complications. A link to this week's article can be found, here: Exploring the Role of Neutrophil Extracellular Traps in Systemic Lupus Erythematosus: A Clinical Case Study and Comprehensive Review 

01/19/25The Healthy Matters PodcastS04_E07 - Let's Learn About Lupus!Did you know that in 2024, over 200,000 people in the U.S. alone had Lupus?  It's a condition that many of us have likely heard of, but it's one that often presents with a lot of questions - like where does it come from?  Who is most likely to get Lupus?  Is it a life-long condition?  And what help is available for those living with it?On the next episode of the show, we'll be joined by Rheumatologist, Dr. Rawad Nasr, and he'll help us get our brains around Lupus, as well as the basics of autoimmune diseases at large.  This is one condition that has seen a lot of progress in terms of treatments and medications over the past decade (finally!), so this is a great chance to get some up-to-date knowledge from an expert in the field.  He'll discuss the origins of the condition (and the name!), who's at risk, what help is available from the medical community, and ways we all can support those living with it.  Come get wise with us!We're open to your comments or ideas for future shows!Email - healthymatters@hcmed.orgCall - 612-873-TALK (8255)Get a preview of upcoming shows on social media and find out more about our show at www.healthymatters.org.

Revero Clinic for treating chronic diseases: https://revero.com Join Revero Now to transform your health: https://revero.com/membership Miranda overcame fibromyalgia, angina, and Lyme disease while also finding relief from anxiety and PTSD; her eyesight improved with a reduction in eye floaters, her spinal disc pain subsided, she achieved a 62-pound weight loss, gained mental clarity, and experienced improved libido. Instagram: https://www.instagram.com/woemaranda/ Twitter: https://x.com/wayofeating Tik Tok: @wayofeating Timestamps: 00:00 Trailer and introduction. 03:24 Endured severe pain; suspected MS diagnosis journey. 07:42 Struggled with illness and obtaining license. 10:56 Coaches ease journey; ignore unsolicited health advice. 15:23 Rheumatologist supports strict carnivore diet plan. 17:40 Rejects services; questions unhealthy food deliveries. 22:25 Higher fat diet improved hormonal health post-hysterectomy. 24:47 Early challenges, adjusted habits, no longer crave. 29:19 Eating beef fat snacks; increase protein for muscle. 29:59 Oxalate detox is minor compared to past struggles. 33:29 Fix diet instead of taking unnecessary supplements. 39:02 Struggled with health, finally feels normal. 40:13 Where to find Maranda. Join the Revero team (medical providers, etc): https://revero.com/jobs ‪#Revero #ReveroHealth #shawnbaker  #Carnivorediet #MeatHeals #AnimalBased #ZeroCarb #DietCoach  #FatAdapted #Carnivore #sugarfree Disclaimer: The content on this channel is not medical advice. Please consult your healthcare provider. ‪#revero #shawnbaker #Carnivorediet #MeatHeals #HealthCreation   #humanfood #AnimalBased #ZeroCarb #DietCoach  #FatAdapted #Carnivore #sugarfree  ‪

Happy New Year, Dear Listener! We're back for 2025 and have with us Dr. Carol Langford, President of The American College of Rheumatology (ACR) and Dr. Adam Goode, President of The Association of Rheumatology Professionals (ARP) as our guests. In this episode you'll get an in-depth look at the collaborative efforts driving the ACR and ARP, direct from our leadership!   Dr. Langford and Dr. Goode share with us their journeys into leadership, key initiatives for this year and their vision for advancing the field of rheumatology. We'll also discuss workforce shortages, technological advancements affecting our field and fostering a more inclusive community. 

Today, I'm thrilled to introduce Dr. Cristina Padilla, a remarkable physician I had the pleasure of meeting at a recent conference. In this episode, we delve into the work being done at the Pittsburgh Scleroderma Center, where Dr. Padilla focuses on translational research into interstitial lung disease. Through our conversation, you'll not only learn about her invaluable contributions to the field but also hear her deep passion for advancing scleroderma research and improving patient care. Let's get started!

Dr. Pui Y. Lee, a pediatric rheumatologist, leading researcher and clinician, joins us today to lend his insights on Deficiency of Adenosine Deaminase 2 or “DADA 2”. What is this disease and how common is it? What is the underlying pathophysiology, the role of genetic screening and the most useful diagnostic tools? We'll also cover treatment options for DADA 2, the prognosis most patients face, plus the future of research for this condition. 

In this episode, we sit down with Dr. Victoria Werth, a leading expert in dermatology and autoimmune diseases, to explore the study Understanding the Role of Type I Interferons in Cutaneous Lupus and Dermatomyositis: Toward Better Therapeutics. Dr. Werth delves into the complex immune mechanisms that drive skin manifestations in cutaneous lupus and dermatomyositis, two challenging autoimmune conditions. She explains how Type I interferons contribute to inflammation and tissue damage, and how understanding these pathways could pave the way for more targeted and effective treatment

As 2024 ends, the ACR's Government Affairs Committee looks ahead to the 119th Congress to address key issues in rheumatology. For our second annual legislative and policy update, we're joined by Dr. Lennie McDaniel, head of ACR's Washington DC office, and Dr. Christina Downey, Chair of the Government Affairs Committee, to share insights from their ACR Convergence 2024 session. Topics include Medicare cuts, physician payments, pharmacy benefit managers (PBMs), telemedicine reimbursement changes, and how you can advocate for better outcomes with the ACR. 

In this episode, we explore the findings of a groundbreaking study analyzing opioid treatment trends for adults with and without systemic autoimmune and inflammatory rheumatic diseases (SARDs) from 2006 to 2019. The study, based on national data from the United States, sheds light on how individuals with conditions like rheumatoid arthritis, lupus, and ankylosing spondylitis are impacted by opioid use compared to the general population. 

We're reporting live from the American College of Rheumatology (ACR) Convergence 2024 in Washington, D.C., a yearly gathering for rheumatology experts worldwide. Join us as we talk to rheumatologists, researchers, and patients to discover how these advancements in research are shaping the future of health and advocacy. Among the highlights in this episode: 00:43: Dr. Sharon Dowell discusses her background as a rheumatologist and her favorite ACR session, "Thieves Market," which emphasizes the diversity of rheumatology cases 01:27: Dr. Dowell explains how events like ACR enhance advocacy by providing opportunities for networking and sharing global perspectives on patient care 02:24: Dr. Swamy Venuturupalli shares his excitement about lupus-specific sessions, especially on CAR T cell therapy, and how these advancements could help his patients 03:36: Dr. Venuturupalli emphasizes the importance of ACR as a global platform for learning and collaboration in rheumatology research 04:25: Cristina Montoya, a registered dietitian and patient advocate, shares her experience presenting on unrecognized symptoms of rheumatic diseases 05:29: Cristina highlights her work with the OMERACT Children's Disease Working Group and her contributions to developing new outcomes for clinical trials 06:44: Dr. Shilpa Venkatachalam reflects on the patient-centered focus at ACR 2024 and the collaborative advancements in biologics and treatment modalities 09:02: Dr. Venkatachalam explains the value of patient-centered research in making invisible diseases visible through patient-reported outcomes and clinical data 12:06: Dr. Venkatachalam discusses how tools like PatientSpot empower patients to advocate for themselves by providing a full picture of their lived experiences For more information about PatientSpot, visit: https://patientspot.org/ 13:14: Zoe wraps up the episode, emphasizing the significance of research presented at ACR in improving patient outcomes and advocacy efforts Contact Our Hosts Steven Newmark, Chief of Policy at GHLF: snewmark@ghlf.org Zoe Rothblatt, Director of Community Outreach at GHLF: zrothblatt@ghlf.org A podcast episode produced by Ben Blanc, Associate Director, Digital Production and Engagement at GHLF. We want to hear what you think. Send your comments in the form of an email, video, or audio clip of yourself to podcasts@ghlf.org Catch up on all our episodes on our website or on your favorite podcast channel.See omnystudio.com/listener for privacy information.

We are proud to present the highly anticipated “ACR 2024 Lupus Nephritis Guideline” with First Author and frequent guest, Dr. Lisa R. Sammaritano. A decade in the making, we reflect on the significant advancements in available therapies, the guideline's holistic approach to managing Lupus Nephritis (LN) across all age groups, and include insights on combination therapies, minimizing glucocorticoid use and how to manage the full spectrum of patients with Lupus Nephritis. 

Today, I'm thrilled to chat with Dr. Deanna Baker Frost—whom I had the privilege of meeting at the National Scleroderma Conference. When I asked her to join me on the podcast, she agreed enthusiastically, requesting a topic that would be impactful for patients. I suggested osteoporosis, given that 80% of scleroderma patients are women, and 80% of the estimated 10 million Americans with osteoporosis are women, too. In this episode, we dive into everything osteoporosis. Buckle up—there's a lot to learn!”

As we continue to highlight sessions from Convergence 2024, we came upon this talk we think you should not miss: Emerging Threats in Rheumatology: Chronic Chikungunya Arthritis and Syphilis Mimicking Rheumatic Diseases. Session presenters, Dr. Jose Kennedy Amaral Pereira and Dr. Daniela DiMarco help us explore the world of emerging threats in rheumatology: specifically, Chikungunya Arthritis and Syphilis. These two experts share insights with us to help diagnose and manage those with these devastating infections and highlight for us how important it is for rheumatologists to remain on high alert for these infections, which can be easily mistaken for more common rheumatic disorders! 

Can Artificial Intelligence (AI) ever replace the clinician or the researcher? Today, we explore the promises and pitfalls of this transformative technology and its implications for rheumatology. From assistance in diagnosis and patient care to its role in research and academic writing, our two guests Dr. Amanda Nelson and Dr. Bella Mehta will walk us through how our field is utilizing AI today and where it may lead in the near future. Most of all, they'll explain how we can harness its power...without getting burned.